I don't like to reply to ploys either. Who would? You wrote earlier "the market seems to side with us and BIIB hasn't made any sort of major move today". You must not have been aware of your error. Today Biogen gained $7.50/share, up 2.47% and closed at $313.59 with high volume.
This "Using similar science" topic has been quite lengthy, not started by either of us, and illustrates an interest in what is going on about AD outside the little world of Prana Biotech. It includes good news for research like Biogen and their licensed partner who were given FDA Fast Track and participation in the EMA's PRIME program. There are others like Lilly/AstraZeneca who also have Fast Track for their BACE Inhibitor and will announce Phase III data later this year. Many who presented at AAIC are moving ahead. There's more to come at medical conferences before the end of the year.
- Forums
- ASX - By Stock
- ATH
- Using similar science
Using similar science, page-18
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
-0.001(12.5%) |
Mkt cap ! $18.62M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $7.902K | 2.037M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 53603756 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 126995306 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
40 | 53603756 | 0.003 |
61 | 91668098 | 0.002 |
28 | 124611099 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 126995306 | 20 |
0.005 | 32272632 | 28 |
0.006 | 15118927 | 23 |
0.007 | 55054408 | 29 |
0.008 | 19128275 | 23 |
Last trade - 14.03pm 15/08/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online